It suppresses apoptosis in lapatinib-resistant HER2+ breast cancer, indicating a potential role for MDM2 inhibition in overcoming lapatinib resistance (Kurokawa et al., 2013). The gene discussed is MDM2; the disease is breast carcinoma.